Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Burley

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2020
Multielectrode ArraysRussell Burley, Jenna R M Harvey
European Journal of Pharmacology|December 6, 2005
Analysis of human Nav1.8 expressed in SH-SY5Y neuroblastoma cellsLodewijk V Dekker, Zoe Daniels, Caroline Hick, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2006
Synthesis and SAR of novel 2-arylthiazolidinones as selective analgesic N-type calcium channel blockersLars J S Knutsen, Christopher J Hobbs, Christopher G Earnshaw, et al.
Neurochemical Research|June 8, 2023
Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for SchizophreniaRosa Fradley, Pascal Goetghebeur, David Miller, et al.
Neurochemical Research|July 13, 2023
Correction to: Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for SchizophreniaRosa Fradley, Pascal Goetghebeur, David Miller, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2022
Synthesis and SAR of novel GPR39 agonists and positive allosteric modulatorsRussell Burley, Richard C Hewer, Martin Teall, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 2, 2021
Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L Brice, Hans H Schiffer, Holger Monenschein, et al.
Cell Reports|June 1, 2017
Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALSClaire E Hall, Zhi Yao, Minee Choi, et al.
Neuropharmacology|November 14, 2022
Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasomeBernardino Ossola, Ali Rifat, Anna Rowland, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2020
Multielectrode ArraysRussell Burley, Jenna R M Harvey
European Journal of Pharmacology|December 6, 2005
Analysis of human Nav1.8 expressed in SH-SY5Y neuroblastoma cellsLodewijk V Dekker, Zoe Daniels, Caroline Hick, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2006
Synthesis and SAR of novel 2-arylthiazolidinones as selective analgesic N-type calcium channel blockersLars J S Knutsen, Christopher J Hobbs, Christopher G Earnshaw, et al.
Neurochemical Research|June 8, 2023
Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for SchizophreniaRosa Fradley, Pascal Goetghebeur, David Miller, et al.
Neurochemical Research|July 13, 2023
Correction to: Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for SchizophreniaRosa Fradley, Pascal Goetghebeur, David Miller, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2022
Synthesis and SAR of novel GPR39 agonists and positive allosteric modulatorsRussell Burley, Richard C Hewer, Martin Teall, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 2, 2021
Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L Brice, Hans H Schiffer, Holger Monenschein, et al.
Cell Reports|June 1, 2017
Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALSClaire E Hall, Zhi Yao, Minee Choi, et al.
Neuropharmacology|November 14, 2022
Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasomeBernardino Ossola, Ali Rifat, Anna Rowland, et al.
Pageof 1